Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells

Citation

Yuan, Y, Cai, T, Callaghan, R et al 2019, 'Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells', International journal of nanomedicine, vol. 14, no. -, pp. 2207-2218.

Year

2019

Fields of Research

  • Biochemistry And Cell Biology Not Elsewhere Classified
  • Receptors And Membrane Biology
  • Structural Biology (Incl. Macromolecular Modelling)

Updated:  19 September 2021 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers